Art

J-GLOBAL ID：201502296027258960   Reference number：15A0468114

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

転移性結腸直腸癌におけるextended RAS変異と抗EGFRモノクローナル抗体生存便益 ランダム化比較試験のメタ分析

Author (6)： SORICH M. J. (Flinders Univ., Adelaide) ,  WIESE M. D. (Univ. South Australia, Adelaide) ,  ROWLAND A. (Flinders Univ., Adelaide) ,  KICHENADASSE G. (Flinders Univ., Adelaide) ,  MCKINNON R. A. (Flinders Univ., Adelaide) ,  KARAPETIS C. S. (Flinders Univ., Adelaide)
Material： Annals of Oncology  (Ann Oncol)
Volume： 26  Issue： 1  Page： 13-21  Publication year： Jan. 2015 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： RAS変異 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0468114&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (3)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (26)：

• Dahabreh IJ, Terasawa T, Castaldi PJ, Trikalinos TA. Systematic review: anti-epidermal growth factor receptor treatment effect modification by KRAS mutations. Ann Intern Med 2011 ; 154: 37-49.
• Behl AS, Goddard KAB, Flottemesch TJ et al. Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst 2012; 104: 1785-1795.
• Douillard JY, Oliner KS, Siena S et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med 2013; 369: 1023-1034.
• Adelstein B-A, Dobbins TA, Harris CA et al. A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer. Eur J Cancer 2011 ; 47: 1343-1354.
• Vale CL, Tierney JF, Fisher D et al. Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treat Rev 2012; 38: 618-625.

Terms in the title (9)： 転移性結腸直腸癌 ,  Ras ,  変異 ,  EGFR ,  モノクローナル抗体 ,  生存 ,  便益 ,  ランダム化比較試験 ,  メタ分析